XYL Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Xylem Inc - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 136.09 USD 0.07%

Updated:

Section:

Wall Street
Price Targets

Wall Street analysts forecast XYL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for XYL is 142.87 USD with a low forecast of 111.1 USD and a high forecast of 164.85 USD.

XYL Lowest Forecast

Wall Street Target

XYL Average Forecast

Wall Street Target

XYL Highest Forecast

Wall Street Target

18% Downside

5% Upside

21% Upside

The latest public price target was made on Apr 8, 2024 by Brad Hewitt from Wolfe Research , who expects XYL stock to rise by 5% over the next 12 months. You can read more about this price target by viewing the article on TheFly.

Analyst	Price Target	Date	Article
Brad Hewitt Wolfe Research	143 USD Upside 5%	3 weeks ago Apr 8, 2024	Xylem price target raised to $143 from $138 at Wolfe Research TheFly
Deane Dray RBC Capital	153 USD Upside 12%	4 weeks ago Apr 4, 2024	Xylem price target raised to $153 from $145 at RBC Capital TheFly
Nathan Jones Stifel Nicolaus	133 USD Downside 2%	8 months ago Aug 18, 2023	Xylem And Evoqua Merger: The Blueprint For Leading Global Smart Water Infrastructure, Predicts Analyst Benzinga
Unknown Analyst Citigroup	121 USD Downside 11%	1 year ago Feb 8, 2023	Citigroup Maintains Neutral on Xylem, Lowers Price Target to $121 Benzinga

Price Target	143 USD
Upside/Downside	5%

Price Target	153 USD
Upside/Downside	12%

Price Target	133 USD
Upside/Downside	2%

Price Target	121 USD
Upside/Downside	11%

Co2 Capsol AS

55% Upside

Graco Inc

12% Upside

Kaulin Manufacturing Co Ltd

138% Upside

Kanematsu Engineering Co Ltd

1% Upside

Co2 Capsol AS

55% Upside

Graco Inc

12% Upside

Kaulin Manufacturing Co Ltd

138% Upside

Kanematsu Engineering Co Ltd

1% Upside

Tsukishima Kikai Co Ltd

11% Upside

Aalberts NV

7% Upside

Timken India Ltd

11% Downside

Estic Corp

87% Upside

Revenue
Forecast

For the last 8 years the compound annual growth rate for Xylem Inc's revenue is 9%. The projected CAGR for the next 3 years is 9%.

9%

9%

-1%

What are analyst estimates?

Operating Income
Forecast

For the last 8 years the compound annual growth rate for Xylem Inc's operating income is 7%. The projected CAGR for the next 3 years is 27%.

7%

27%

-6%

What are analyst estimates?

Net Income
Forecast

For the last 8 years the compound annual growth rate for Xylem Inc's net income is 8%. The projected CAGR for the next 3 years is 28%.

8%

28%

-43%

What are analyst estimates?

See Also

Relative Valuation

Wall Street Estimates

Profitability Analysis

Solvency Analysis

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

According to Wall Street analysts, the average 1-year price target for XYL is 142.87 USD with a low forecast of 111.1 USD and a high forecast of 164.85 USD.

For the last 8 years the compound annual growth rate for Xylem Inc's revenue is 9%. The projected CAGR for the next 3 years is 9%.

For the last 8 years the compound annual growth rate for Xylem Inc's operating income is 7%. The projected CAGR for the next 3 years is 27%.

For the last 8 years the compound annual growth rate for Xylem Inc's net income is 8%. The projected CAGR for the next 3 years is 28%.

Join more than 133,800+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.